Skip to content

Clinical trials

Completed Neoplasms by Site trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms by Site Status: Completed Country / region: Netherlands Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20113
20121
20131
20141
20152
20162
20172
20181

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb2
Steba Biotech S.A.2
Sumitomo Pharma America, Inc.2
Aragon Pharmaceuticals, Inc.1
BBB-Therapeutics B.V.1
BeiGene USA, Inc.1
Celgene1
Hoffmann-La Roche1
Merck KGaA, Darmstadt, Germany1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms by Site14
Neoplasms12
Carcinoma5
Neoplasms by Histologic Type5
Adenocarcinoma4
Digestive System Diseases4
Digestive System Neoplasms4
Neoplasms, Glandular and Epithelial4
Urogenital Neoplasms4
Endocrine Gland Neoplasms3

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.